Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics

Wall Street analysts expect GE HealthCare Technologies (GEHC) to post quarterly earnings of $1.06 per share in its upcoming report, which indicates a year-over-year increase of 7.1%. Revenues are expected to be $4.86 billion, up 0.9% from the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.Bearing this in mind, let's now explore the average estimates of specific GE HealthCare metrics that are commonly monitored and projected by Wall Street analysts.Analysts forecast 'Revenues- Imaging' to reach $2.63 billion. The estimate indicates a change of -0.3% from the prior-year quarter.It is projected by analysts that the 'Revenues- Ultrasound' will reach $823.95 million. The estimate indicates a year-over-year change of +1.1%.Analysts predict that the 'Revenues- Other' will reach $10.52 million. The estimate suggests a change of -44.6% year over year.Analysts' assessment points toward 'Revenues- PDx' reaching $634.60 million. The estimate points to a change of +7.7% from the year-ago quarter.The average prediction of analysts places 'Revenues- PCS' at $775.36 million. The estimate points to a change of +1.5% from the year-ago quarter.View all Key Company Metrics for GE HealthCare here>>>GE HealthCare shares have witnessed a change of -3.9% in the past month, in contrast to the Zacks S&P 500 composite's +2% move. With a Zacks Rank #3 (Hold), GEHC is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GE HealthCare Technologies Inc. (GEHC): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks